Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.

Nixon DR, Yan DB, Chartrand JP, Piemontesi RL, Simonyi S, Hollander DA.

Curr Med Res Opin. 2009 Jul;25(7):1645-53. doi: 10.1185/03007990902994041.

PMID:
19476406
[PubMed - indexed for MEDLINE]
2.

Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%-timolol 0.5% therapy.

Motolko MA.

Curr Med Res Opin. 2008 Sep;24(9):2663-7. doi: 10.1185/03007990802333167 . Epub 2008 Aug 7.

PMID:
18691444
[PubMed - indexed for MEDLINE]
3.

Bimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension.

Brandt JD, Cantor LB, Katz LJ, Batoosingh AL, Chou C, Bossowska I; Ganfort Investigators Group II.

J Glaucoma. 2008 Apr-May;17(3):211-6. doi: 10.1097/IJG.0b013e3181507313. Erratum in: J Glaucoma. 2010 Aug;19(6):423.

PMID:
18414107
[PubMed - indexed for MEDLINE]
4.

Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.

Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.

Ann Pharmacother. 2008 Apr;42(4):498-504. doi: 10.1345/aph.1K565. Epub 2008 Mar 25.

PMID:
18364402
[PubMed - indexed for MEDLINE]
5.

Cost analysis of glaucoma medications.

Rylander NR, Vold SD.

Am J Ophthalmol. 2008 Jan;145(1):106-13.

PMID:
18154755
[PubMed - indexed for MEDLINE]
6.

Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study.

Gellad WF, Haas JS, Safran DG.

J Gen Intern Med. 2007 Nov;22(11):1572-8. Epub 2007 Sep 20.

PMID:
17882499
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Ocular comfort of combination glaucoma therapies: brimonidine 0.2%/timolol 0.5% compared with dorzolamide 2%/timolol 0.5%.

Chan K, Testa M, McCluskey P.

J Ocul Pharmacol Ther. 2007 Aug;23(4):372-6.

PMID:
17803436
[PubMed - indexed for MEDLINE]
8.

Comparing the fixed combination brimonidine-timolol versus fixed combination dorzolamide-timolol in patients with elevated intraocular pressure.

Arcieri ES, Arcieri RS, Pereira AC, Andreo EG, Finotti IG, Sá Filho WF.

Curr Med Res Opin. 2007 Apr;23(4):683-9.

PMID:
17407624
[PubMed - indexed for MEDLINE]
9.
10.

Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.

Sherwood MB, Craven ER, Chou C, DuBiner HB, Batoosingh AL, Schiffman RM, Whitcup SM.

Arch Ophthalmol. 2006 Sep;124(9):1230-8.

PMID:
16966616
[PubMed - indexed for MEDLINE]
11.

Patient-reported behavior and problems in using glaucoma medications.

Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B.

Ophthalmology. 2006 Mar;113(3):431-6. Epub 2006 Feb 3.

PMID:
16458967
[PubMed - indexed for MEDLINE]
12.

Efficacy of latanoprost or fixed-combination latanoprost-timolol in patients switched from a combination of timolol and a nonprostaglandin medication.

Magacho L, Reis R, Shetty RK, Santos LC, Avila MP.

Ophthalmology. 2006 Mar;113(3):442-5. Epub 2006 Feb 3.

PMID:
16458964
[PubMed - indexed for MEDLINE]
13.

A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components.

Diestelhorst M, Larsson LI; European-Canadian Latanoprost Fixed Combination Study Group.

Ophthalmology. 2006 Jan;113(1):70-6. Epub 2005 Nov 2.

PMID:
16263174
[PubMed - indexed for MEDLINE]
14.

Rate and determinants of 10-year persistence with antihypertensive drugs.

Van Wijk BL, Klungel OH, Heerdink ER, de Boer A.

J Hypertens. 2005 Nov;23(11):2101-7.

PMID:
16208154
[PubMed - indexed for MEDLINE]
15.

12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension.

Goñi FJ; Brimonidine/Timolol Fixed Combination Study Group.

Eur J Ophthalmol. 2005 Sep-Oct;15(5):581-90.

PMID:
16167288
[PubMed - indexed for MEDLINE]
17.

Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.

Schuman JS, Katz GJ, Lewis RA, Henry JC, Mallick S, Wells DT, Sullivan EK, Landry TA, Bergamini MV, Robertson SM.

Am J Ophthalmol. 2005 Aug;140(2):242-50.

PMID:
16086946
[PubMed - indexed for MEDLINE]
18.

The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.

Barnebey HS, Orengo-Nania S, Flowers BE, Samples J, Mallick S, Landry TA, Bergamini MV.

Am J Ophthalmol. 2005 Jul;140(1):1-7.

PMID:
15990081
[PubMed - indexed for MEDLINE]
19.

Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review.

Olthoff CM, Schouten JS, van de Borne BW, Webers CA.

Ophthalmology. 2005 Jun;112(6):953-61. Review.

PMID:
15885795
[PubMed - indexed for MEDLINE]
20.

Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?

Robin AL, Covert D.

Ophthalmology. 2005 May;112(5):863-8.

PMID:
15878067
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk